US Stock MarketDetailed Quotes

DMAC DiaMedica Therapeutics

Watchlist
  • 2.900
  • +0.130+4.69%
Close May 31 16:00 ET
  • 2.900
  • 0.0000.00%
Post 16:01 ET
110.10MMarket Cap-5370P/E (TTM)

DiaMedica Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

DiaMedica Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.14

+30.00%
Analyst Rating

Strong Buy

Jun 1, 2024

DiaMedica Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 8, 20242024/Q10.000 / 0.000--
Mar 20, 20242023/Q40.000 / 0.000--
Nov 13, 20232023/Q30.000 / 0.000--
Aug 14, 20232023/Q20.000 / 0.000--
May 15, 20232023/Q10.000 / 0.000--
Mar 28, 20232022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
Aug 10, 20222022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 8, 20242024/Q10.000 / 0.000--
Mar 20, 20242023/Q40.000 / 0.000--
Nov 13, 20232023/Q30.000 / 0.000--
Aug 14, 20232023/Q20.000 / 0.000--
May 15, 20232023/Q10.000 / 0.000--
Mar 28, 20232022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
Aug 10, 20222022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

DiaMedica Therapeutics Earnings Reports

  • DiaMedica Therapeutics | 10-Q: Quarterly report

    May 8 15:41

  • DiaMedica Therapeutics | 10-K: Annual report

    Mar 19 15:22

  • DiaMedica Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 15:55

  • DiaMedica Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 15:29

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 1, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg